The Benfotiamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Benfotiamine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. DietarySupplement accounting for % of the Benfotiamine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pharma Grade segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Benfotiamine include Klaire, Hamari, BioXera Pharma, Kimia Biosciences, and AOR, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Benfotiamine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pharma Grade
Food Grade
Market segment by Application can be divided into
DietarySupplement
Diabetic Neuropathy
Others
The key market players for global Benfotiamine market are listed below:
Klaire
Hamari
BioXera Pharma
Kimia Biosciences
AOR
Country Life Vitamins
Neurohacker Collective
XY Mogen
Pharmaffiliates
Hangzhou Eastbiopharm
Basil Pharmaceuticals
Ami Lifesciences
Kaival Chemicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Benfotiamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Benfotiamine, with price, sales, revenue and global market share of Benfotiamine from 2019 to 2022.
Chapter 3, the Benfotiamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benfotiamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Benfotiamine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Benfotiamine.
Chapter 13, 14, and 15, to describe Benfotiamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Benfotiamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Benfotiamine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pharma Grade
1.2.3 Food Grade
1.3 Market Analysis by Application
1.3.1 Overview: Global Benfotiamine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 DietarySupplement
1.3.3 Diabetic Neuropathy
1.3.4 Others
1.4 Global Benfotiamine Market Size & Forecast
1.4.1 Global Benfotiamine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Benfotiamine Sales in Volume (2017-2028)
1.4.3 Global Benfotiamine Price (2017-2028)
1.5 Global Benfotiamine Production Capacity Analysis
1.5.1 Global Benfotiamine Total Production Capacity (2017-2028)
1.5.2 Global Benfotiamine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Benfotiamine Market Drivers
1.6.2 Benfotiamine Market Restraints
1.6.3 Benfotiamine Trends Analysis
2 Manufacturers Profiles
2.1 Klaire
2.1.1 Klaire Details
2.1.2 Klaire Major Business
2.1.3 Klaire Benfotiamine Product and Services
2.1.4 Klaire Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hamari
2.2.1 Hamari Details
2.2.2 Hamari Major Business
2.2.3 Hamari Benfotiamine Product and Services
2.2.4 Hamari Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BioXera Pharma
2.3.1 BioXera Pharma Details
2.3.2 BioXera Pharma Major Business
2.3.3 BioXera Pharma Benfotiamine Product and Services
2.3.4 BioXera Pharma Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kimia Biosciences
2.4.1 Kimia Biosciences Details
2.4.2 Kimia Biosciences Major Business
2.4.3 Kimia Biosciences Benfotiamine Product and Services
2.4.4 Kimia Biosciences Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AOR
2.5.1 AOR Details
2.5.2 AOR Major Business
2.5.3 AOR Benfotiamine Product and Services
2.5.4 AOR Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Country Life Vitamins
2.6.1 Country Life Vitamins Details
2.6.2 Country Life Vitamins Major Business
2.6.3 Country Life Vitamins Benfotiamine Product and Services
2.6.4 Country Life Vitamins Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Neurohacker Collective
2.7.1 Neurohacker Collective Details
2.7.2 Neurohacker Collective Major Business
2.7.3 Neurohacker Collective Benfotiamine Product and Services
2.7.4 Neurohacker Collective Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 XY Mogen
2.8.1 XY Mogen Details
2.8.2 XY Mogen Major Business
2.8.3 XY Mogen Benfotiamine Product and Services
2.8.4 XY Mogen Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pharmaffiliates
2.9.1 Pharmaffiliates Details
2.9.2 Pharmaffiliates Major Business
2.9.3 Pharmaffiliates Benfotiamine Product and Services
2.9.4 Pharmaffiliates Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hangzhou Eastbiopharm
2.10.1 Hangzhou Eastbiopharm Details
2.10.2 Hangzhou Eastbiopharm Major Business
2.10.3 Hangzhou Eastbiopharm Benfotiamine Product and Services
2.10.4 Hangzhou Eastbiopharm Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Basil Pharmaceuticals
2.11.1 Basil Pharmaceuticals Details
2.11.2 Basil Pharmaceuticals Major Business
2.11.3 Basil Pharmaceuticals Benfotiamine Product and Services
2.11.4 Basil Pharmaceuticals Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Ami Lifesciences
2.12.1 Ami Lifesciences Details
2.12.2 Ami Lifesciences Major Business
2.12.3 Ami Lifesciences Benfotiamine Product and Services
2.12.4 Ami Lifesciences Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Kaival Chemicals
2.13.1 Kaival Chemicals Details
2.13.2 Kaival Chemicals Major Business
2.13.3 Kaival Chemicals Benfotiamine Product and Services
2.13.4 Kaival Chemicals Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Benfotiamine Breakdown Data by Manufacturer
3.1 Global Benfotiamine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Benfotiamine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Benfotiamine
3.4 Market Concentration Rate
3.4.1 Top 3 Benfotiamine Manufacturer Market Share in 2021
3.4.2 Top 6 Benfotiamine Manufacturer Market Share in 2021
3.5 Global Benfotiamine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Benfotiamine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Benfotiamine Market Size by Region
4.1.1 Global Benfotiamine Sales in Volume by Region (2017-2028)
4.1.2 Global Benfotiamine Revenue by Region (2017-2028)
4.2 North America Benfotiamine Revenue (2017-2028)
4.3 Europe Benfotiamine Revenue (2017-2028)
4.4 Asia-Pacific Benfotiamine Revenue (2017-2028)
4.5 South America Benfotiamine Revenue (2017-2028)
4.6 Middle East and Africa Benfotiamine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Benfotiamine Sales in Volume by Type (2017-2028)
5.2 Global Benfotiamine Revenue by Type (2017-2028)
5.3 Global Benfotiamine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Benfotiamine Sales in Volume by Application (2017-2028)
6.2 Global Benfotiamine Revenue by Application (2017-2028)
6.3 Global Benfotiamine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Benfotiamine Sales by Type (2017-2028)
7.2 North America Benfotiamine Sales by Application (2017-2028)
7.3 North America Benfotiamine Market Size by Country
7.3.1 North America Benfotiamine Sales in Volume by Country (2017-2028)
7.3.2 North America Benfotiamine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Benfotiamine Sales by Type (2017-2028)
8.2 Europe Benfotiamine Sales by Application (2017-2028)
8.3 Europe Benfotiamine Market Size by Country
8.3.1 Europe Benfotiamine Sales in Volume by Country (2017-2028)
8.3.2 Europe Benfotiamine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Benfotiamine Sales by Type (2017-2028)
9.2 Asia-Pacific Benfotiamine Sales by Application (2017-2028)
9.3 Asia-Pacific Benfotiamine Market Size by Region
9.3.1 Asia-Pacific Benfotiamine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Benfotiamine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Benfotiamine Sales by Type (2017-2028)
10.2 South America Benfotiamine Sales by Application (2017-2028)
10.3 South America Benfotiamine Market Size by Country
10.3.1 South America Benfotiamine Sales in Volume by Country (2017-2028)
10.3.2 South America Benfotiamine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Benfotiamine Sales by Type (2017-2028)
11.2 Middle East & Africa Benfotiamine Sales by Application (2017-2028)
11.3 Middle East & Africa Benfotiamine Market Size by Country
11.3.1 Middle East & Africa Benfotiamine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Benfotiamine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Benfotiamine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Benfotiamine
12.3 Benfotiamine Production Process
12.4 Benfotiamine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Benfotiamine Typical Distributors
13.3 Benfotiamine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Benfotiamine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Benfotiamine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Klaire Basic Information, Manufacturing Base and Competitors
Table 4. Klaire Major Business
Table 5. Klaire Benfotiamine Product and Services
Table 6. Klaire Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Hamari Basic Information, Manufacturing Base and Competitors
Table 8. Hamari Major Business
Table 9. Hamari Benfotiamine Product and Services
Table 10. Hamari Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BioXera Pharma Basic Information, Manufacturing Base and Competitors
Table 12. BioXera Pharma Major Business
Table 13. BioXera Pharma Benfotiamine Product and Services
Table 14. BioXera Pharma Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kimia Biosciences Basic Information, Manufacturing Base and Competitors
Table 16. Kimia Biosciences Major Business
Table 17. Kimia Biosciences Benfotiamine Product and Services
Table 18. Kimia Biosciences Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AOR Basic Information, Manufacturing Base and Competitors
Table 20. AOR Major Business
Table 21. AOR Benfotiamine Product and Services
Table 22. AOR Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Country Life Vitamins Basic Information, Manufacturing Base and Competitors
Table 24. Country Life Vitamins Major Business
Table 25. Country Life Vitamins Benfotiamine Product and Services
Table 26. Country Life Vitamins Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Neurohacker Collective Basic Information, Manufacturing Base and Competitors
Table 28. Neurohacker Collective Major Business
Table 29. Neurohacker Collective Benfotiamine Product and Services
Table 30. Neurohacker Collective Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. XY Mogen Basic Information, Manufacturing Base and Competitors
Table 32. XY Mogen Major Business
Table 33. XY Mogen Benfotiamine Product and Services
Table 34. XY Mogen Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pharmaffiliates Basic Information, Manufacturing Base and Competitors
Table 36. Pharmaffiliates Major Business
Table 37. Pharmaffiliates Benfotiamine Product and Services
Table 38. Pharmaffiliates Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Hangzhou Eastbiopharm Basic Information, Manufacturing Base and Competitors
Table 40. Hangzhou Eastbiopharm Major Business
Table 41. Hangzhou Eastbiopharm Benfotiamine Product and Services
Table 42. Hangzhou Eastbiopharm Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Basil Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Basil Pharmaceuticals Major Business
Table 45. Basil Pharmaceuticals Benfotiamine Product and Services
Table 46. Basil Pharmaceuticals Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Ami Lifesciences Basic Information, Manufacturing Base and Competitors
Table 48. Ami Lifesciences Major Business
Table 49. Ami Lifesciences Benfotiamine Product and Services
Table 50. Ami Lifesciences Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Kaival Chemicals Basic Information, Manufacturing Base and Competitors
Table 52. Kaival Chemicals Major Business
Table 53. Kaival Chemicals Benfotiamine Product and Services
Table 54. Kaival Chemicals Benfotiamine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Benfotiamine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 56. Global Benfotiamine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Benfotiamine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Benfotiamine Production Capacity by Company, (MT): 2020 VS 2021
Table 59. Head Office and Benfotiamine Production Site of Key Manufacturer
Table 60. Benfotiamine New Entrant and Capacity Expansion Plans
Table 61. Benfotiamine Mergers & Acquisitions in the Past Five Years
Table 62. Global Benfotiamine Sales by Region (2017-2022) & (MT)
Table 63. Global Benfotiamine Sales by Region (2023-2028) & (MT)
Table 64. Global Benfotiamine Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Benfotiamine Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Benfotiamine Sales by Type (2017-2022) & (MT)
Table 67. Global Benfotiamine Sales by Type (2023-2028) & (MT)
Table 68. Global Benfotiamine Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Benfotiamine Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Benfotiamine Price by Type (2017-2022) & (USD/MT)
Table 71. Global Benfotiamine Price by Type (2023-2028) & (USD/MT)
Table 72. Global Benfotiamine Sales by Application (2017-2022) & (MT)
Table 73. Global Benfotiamine Sales by Application (2023-2028) & (MT)
Table 74. Global Benfotiamine Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Benfotiamine Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Benfotiamine Price by Application (2017-2022) & (USD/MT)
Table 77. Global Benfotiamine Price by Application (2023-2028) & (USD/MT)
Table 78. North America Benfotiamine Sales by Country (2017-2022) & (MT)
Table 79. North America Benfotiamine Sales by Country (2023-2028) & (MT)
Table 80. North America Benfotiamine Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Benfotiamine Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Benfotiamine Sales by Type (2017-2022) & (MT)
Table 83. North America Benfotiamine Sales by Type (2023-2028) & (MT)
Table 84. North America Benfotiamine Sales by Application (2017-2022) & (MT)
Table 85. North America Benfotiamine Sales by Application (2023-2028) & (MT)
Table 86. Europe Benfotiamine Sales by Country (2017-2022) & (MT)
Table 87. Europe Benfotiamine Sales by Country (2023-2028) & (MT)
Table 88. Europe Benfotiamine Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Benfotiamine Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Benfotiamine Sales by Type (2017-2022) & (MT)
Table 91. Europe Benfotiamine Sales by Type (2023-2028) & (MT)
Table 92. Europe Benfotiamine Sales by Application (2017-2022) & (MT)
Table 93. Europe Benfotiamine Sales by Application (2023-2028) & (MT)
Table 94. Asia-Pacific Benfotiamine Sales by Region (2017-2022) & (MT)
Table 95. Asia-Pacific Benfotiamine Sales by Region (2023-2028) & (MT)
Table 96. Asia-Pacific Benfotiamine Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Benfotiamine Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Benfotiamine Sales by Type (2017-2022) & (MT)
Table 99. Asia-Pacific Benfotiamine Sales by Type (2023-2028) & (MT)
Table 100. Asia-Pacific Benfotiamine Sales by Application (2017-2022) & (MT)
Table 101. Asia-Pacific Benfotiamine Sales by Application (2023-2028) & (MT)
Table 102. South America Benfotiamine Sales by Country (2017-2022) & (MT)
Table 103. South America Benfotiamine Sales by Country (2023-2028) & (MT)
Table 104. South America Benfotiamine Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Benfotiamine Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Benfotiamine Sales by Type (2017-2022) & (MT)
Table 107. South America Benfotiamine Sales by Type (2023-2028) & (MT)
Table 108. South America Benfotiamine Sales by Application (2017-2022) & (MT)
Table 109. South America Benfotiamine Sales by Application (2023-2028) & (MT)
Table 110. Middle East & Africa Benfotiamine Sales by Region (2017-2022) & (MT)
Table 111. Middle East & Africa Benfotiamine Sales by Region (2023-2028) & (MT)
Table 112. Middle East & Africa Benfotiamine Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Benfotiamine Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Benfotiamine Sales by Type (2017-2022) & (MT)
Table 115. Middle East & Africa Benfotiamine Sales by Type (2023-2028) & (MT)
Table 116. Middle East & Africa Benfotiamine Sales by Application (2017-2022) & (MT)
Table 117. Middle East & Africa Benfotiamine Sales by Application (2023-2028) & (MT)
Table 118. Benfotiamine Raw Material
Table 119. Key Manufacturers of Benfotiamine Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Benfotiamine Typical Distributors
Table 123. Benfotiamine Typical Customers
List of Figures
Figure 1. Benfotiamine Picture
Figure 2. Global Benfotiamine Revenue Market Share by Type in 2021
Figure 3. Pharma Grade
Figure 4. Food Grade
Figure 5. Global Benfotiamine Revenue Market Share by Application in 2021
Figure 6. DietarySupplement
Figure 7. Diabetic Neuropathy
Figure 8. Others
Figure 9. Global Benfotiamine Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Benfotiamine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Benfotiamine Sales (2017-2028) & (MT)
Figure 12. Global Benfotiamine Price (2017-2028) & (USD/MT)
Figure 13. Global Benfotiamine Production Capacity (2017-2028) & (MT)
Figure 14. Global Benfotiamine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Benfotiamine Market Drivers
Figure 16. Benfotiamine Market Restraints
Figure 17. Benfotiamine Market Trends
Figure 18. Global Benfotiamine Sales Market Share by Manufacturer in 2021
Figure 19. Global Benfotiamine Revenue Market Share by Manufacturer in 2021
Figure 20. Benfotiamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Benfotiamine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Benfotiamine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Benfotiamine Sales Market Share by Region (2017-2028)
Figure 24. Global Benfotiamine Revenue Market Share by Region (2017-2028)
Figure 25. North America Benfotiamine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Benfotiamine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Benfotiamine Revenue (2017-2028) & (USD Million)
Figure 28. South America Benfotiamine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Benfotiamine Revenue (2017-2028) & (USD Million)
Figure 30. Global Benfotiamine Sales Market Share by Type (2017-2028)
Figure 31. Global Benfotiamine Revenue Market Share by Type (2017-2028)
Figure 32. Global Benfotiamine Price by Type (2017-2028) & (USD/MT)
Figure 33. Global Benfotiamine Sales Market Share by Application (2017-2028)
Figure 34. Global Benfotiamine Revenue Market Share by Application (2017-2028)
Figure 35. Global Benfotiamine Price by Application (2017-2028) & (USD/MT)
Figure 36. North America Benfotiamine Sales Market Share by Type (2017-2028)
Figure 37. North America Benfotiamine Sales Market Share by Application (2017-2028)
Figure 38. North America Benfotiamine Sales Market Share by Country (2017-2028)
Figure 39. North America Benfotiamine Revenue Market Share by Country (2017-2028)
Figure 40. United States Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Benfotiamine Sales Market Share by Type (2017-2028)
Figure 44. Europe Benfotiamine Sales Market Share by Application (2017-2028)
Figure 45. Europe Benfotiamine Sales Market Share by Country (2017-2028)
Figure 46. Europe Benfotiamine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Benfotiamine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Benfotiamine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Benfotiamine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Benfotiamine Revenue Market Share by Region (2017-2028)
Figure 56. China Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Benfotiamine Sales Market Share by Type (2017-2028)
Figure 63. South America Benfotiamine Sales Market Share by Application (2017-2028)
Figure 64. South America Benfotiamine Sales Market Share by Country (2017-2028)
Figure 65. South America Benfotiamine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Benfotiamine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Benfotiamine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Benfotiamine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Benfotiamine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Benfotiamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Benfotiamine in 2021
Figure 77. Manufacturing Process Analysis of Benfotiamine
Figure 78. Benfotiamine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source